Binge Eating Disorder

Binge Eating Disorder is an eating disorder characterized by recurrent episodes of consuming an unusually large amount of food within a specific short period of time (typically within two hours or less), significantly more than most people would consume in the same time frame. During these episodes, individuals report a loss of control over eating and find it difficult to stop. A distinguishing feature of Binge Eating Disorder (BED) is the absence of compensatory behaviors such as vomiting, excessive exercise, or other purging actions following the binge episodes. In this regard, BED differs clinically from other eating disorders such as bulimia nervosa.

Diagnosis and History

BED was first described by Albert Stunkard in 1959, and diagnostic criteria were later developed by Spitzer and colleagues in 1991. In the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM), BED was initially included as a provisional diagnosis in DSM-IV and was formally recognized as a distinct diagnosis under the category “Feeding and Eating Disorders” in DSM-5, published in May 2013.

According to DSM-5 criteria, a diagnosis of Binge Eating Disorder requires the presence of recurrent binge eating episodes at least once a week for three months. During these episodes, the individual consumes an amount of food that is significantly larger than what most people would eat in a similar period and experiences a sense of lack of control over eating. Negative emotions such as extreme fullness, physical discomfort, guilt, shame, or distress often occur during or after the episodes.

Epidemiology

BED is among the most common eating disorders in adults. The lifetime prevalence varies globally between 0.7% and 6.6%, with approximately 2.8% reported in the United States. It is more common in women than in men (about 1.75 times more frequent). The disorder typically begins in the twenties and may persist into middle age. Prevalence is higher among individuals with obesity, particularly among those receiving weight management treatment and those eligible for bariatric surgery.

Etiology

The etiology of Binge Eating Disorder (BED) is understood to involve an interaction of genetic, biological, psychological, and environmental factors. Twin studies indicate a heritable component, with heritability estimates ranging from 41% to 74%. Neurotransmitter systems including dopamine, serotonin, opioids, and ghrelin have been implicated in BED. Additionally, functional abnormalities in the brain’s reward system are proposed to be associated with binge eating behavior.

Psychological factors include traumatic events experienced in early life and negative beliefs about the self. Clinical observations reveal that individuals diagnosed with BED frequently exhibit low self-esteem, negative body image, difficulties with emotional regulation, impulsivity, and behavioral patterns linked to addiction.

Clinical Features

In Binge Eating Disorder (BED), individuals commonly experience a loss of control during eating episodes. They typically consume large quantities of food rapidly, often without feeling hungry. Following these episodes, individuals frequently report negative emotions such as guilt, shame, or regret, and it is commonly observed that they engage in these eating behaviors in private. BED is associated with weight gain and obesity, which can contribute to various physical health problems.

Psychiatric disorders commonly co-occurring with BED include major depressive disorder, anxiety disorders, and certain personality disorders (avoidant, borderline, obsessive-compulsive). Additionally, medical conditions related to obesity such as type 2 diabetes and cardiovascular disease are frequently present.

Course and Prognosis

Longitudinal studies have shown that BED often follows a chronic course. While symptoms may diminish over time in some individuals, others may transition into other eating disorders.

Treatment

The goals of BED treatment include cessation of binge eating episodes, establishment of regular eating patterns, achievement of weight stability, and management of co-occurring psychiatric conditions.

• Psychotherapy: Approaches such as Cognitive Behavioral Therapy (CBT), Interpersonal Psychotherapy (IPT), and Dialectical Behavior Therapy (DBT) are commonly used. Self-help programs and motivational interviewing techniques can also serve as supportive interventions.
• Pharmacotherapy: Various psychotropic and metabolism-acting medications are used in pharmacological treatment. The general aim of these interventions is to reduce the frequency and severity of binge episodes, regulate mood, and control potential weight gain. The effectiveness of pharmacological treatments is generally reported as moderate. Ongoing clinical research continues to explore new treatment approaches targeting emerging biological pathways.
• Bariatric Surgery: In cases of BED occurring alongside obesity, bariatric surgery may be considered as a treatment option in specific circumstances. However, because there is a risk of persistent binge eating behavior after surgery, multidisciplinary evaluation and long-term follow-up are recommended both before and after the procedure.

Warning: The content in this article is provided solely for general encyclopedic informational purposes. The information presented here should not be used for diagnosis, treatment, or medical advice. Always consult a physician or qualified healthcare professional before making any decisions regarding health. The author and KÜRE Encyclopedia assume no responsibility for any consequences arising from the use of this information for diagnostic or therapeutic purposes.